These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 32521891)
1. Efficacy of transcatheter arterial chemoembolization combined with 125I seed implantation and three-dimensional conformal radiotherapy in advanced primary hepatocellular carcinoma. Zhang H; Yang A; Zhang J J BUON; 2020; 25(2):952-958. PubMed ID: 32521891 [TBL] [Abstract][Full Text] [Related]
2. Sorafenib combined with transarterial chemoembolization prolongs survival of patients with advanced hepatocellular carcinoma. Liu Q; Dai Y J BUON; 2020; 25(2):945-951. PubMed ID: 32521890 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of transcatheter arterial chemoembolization combined with either Li Y; Li H; Hu H; Yuan H; Zhao Y J Cancer Res Ther; 2020; 16(7):1691-1697. PubMed ID: 33565518 [TBL] [Abstract][Full Text] [Related]
4. Lobaplatin-TACE combined with radioactive 125I seed implantation for treatment of primary hepatocellular carcinoma. Peng S; Yang QX; Zhang T; Lu MJ; Yang G; Liu ZY; Zhang R; Zhang FJ Asian Pac J Cancer Prev; 2014; 15(13):5155-60. PubMed ID: 25040967 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis]. Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343 [No Abstract] [Full Text] [Related]
6. Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma. Zhou ZH; Liu LM; Chen WW; Men ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL Br J Radiol; 2007 Mar; 80(951):194-201. PubMed ID: 17038412 [TBL] [Abstract][Full Text] [Related]
7. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Liu MT; Li SH; Chu TC; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Lin JP Jpn J Clin Oncol; 2004 Sep; 34(9):532-9. PubMed ID: 15466827 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of licartin combined with transcatheter hepatic arterial chemoembolization in the treatment of middle-advanced primary liver cancer. Jin J; Zhou T; Lou J; Yan S; Wu Y; Xie M; Wang W J BUON; 2020; 25(6):2584-2591. PubMed ID: 33455100 [TBL] [Abstract][Full Text] [Related]
9. Transarterial Chemoembolization Followed by Radiotherapy Versus Sandwich Treatment for Unresectable or Ablative Hepatocellular Carcinoma. Lin H; Wu H; Cong N; Liu B; Liu C; Han D Technol Cancer Res Treat; 2020; 19():1533033820983799. PubMed ID: 33357168 [TBL] [Abstract][Full Text] [Related]
10. 3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. Zou LQ; Zhang BL; Chang Q; Zhu FP; Li YY; Wei YQ; Guan YS World J Gastroenterol; 2014 Dec; 20(45):17227-34. PubMed ID: 25493039 [TBL] [Abstract][Full Text] [Related]
11. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [TBL] [Abstract][Full Text] [Related]
12. Observation of therapeutic effect of 125I seed implantation combined with chemotherapy and antiviral therapy on HBV-related liver cancer. Zeng Y; Mao Y; Shi Z; Zhou Y; Zhang L J BUON; 2019; 24(4):1414-1419. PubMed ID: 31646785 [TBL] [Abstract][Full Text] [Related]
13. A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma. Choi C; Koom WS; Kim TH; Yoon SM; Kim JH; Lee HS; Nam TK; Seong J Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1051-60. PubMed ID: 25303890 [TBL] [Abstract][Full Text] [Related]
14. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma]. Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612 [TBL] [Abstract][Full Text] [Related]
15. Three-dimensional conformal radiotherapy in combination with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma. Chen WJ; Yuan SF; Zhu LJ; Sun XN; Zheng W J BUON; 2014; 19(3):692-7. PubMed ID: 25261654 [TBL] [Abstract][Full Text] [Related]
16. Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study. Ren ZG; Zhao JD; Gu K; Chen Z; Lin JH; Xu ZY; Hu WG; Zhou ZH; Liu LM; Jiang GL Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):496-502. PubMed ID: 20421145 [TBL] [Abstract][Full Text] [Related]
17. Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study. Zhao JD; Liu J; Ren ZG; Gu K; Zhou ZH; Li WT; Chen Z; Xu ZY; Liu LM; Jiang GL Radiat Oncol; 2010 Feb; 5():12. PubMed ID: 20149262 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy of aparatinib and carrilizumab combined with transcatheter arterial chemoembolization in the treatment of primary hepatocellular carcinoma. Chen C; Duan XT; Li GY; Hao XJ; Wang WL; Shen YF; Zhang SH Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4135-4144. PubMed ID: 37203839 [TBL] [Abstract][Full Text] [Related]
19. [Clinical control of different sequential order of three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma]. Lu D; Tang J; Zhou J; Fei Z; Hu Z; Hao W Zhonghua Gan Zang Bing Za Zhi; 2015 Mar; 23(3):184-8. PubMed ID: 25938830 [TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacy between TACE combined with apatinib and TACE alone in the treatment of intermediate and advanced hepatocellular carcinoma: A single-center randomized controlled trial. Lu W; Jin XL; Yang C; Du P; Jiang FQ; Ma JP; Yang J; Xie P; Zhang Z Cancer Biol Ther; 2017 Jun; 18(6):433-438. PubMed ID: 28548587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]